...Corporate Outlooks Diverge for Emerging, Developed EMEA Credit trends among EMEA corporates will diverge in 2016 as companies in developed markets benefit from gradually improving cash generation and profitability, while their emerging-market (EM) peers contend with higher leverage and weaker cash generation. These trends support an overall stable outlook for EMEA corporates in the coming year, but a negative outlook for emerging EMEA. 2016 Sector Outlook Reports For a full breakdown of our 2016 Sector Outlook reports please visit our dedicated Outlooks page via the hyperlink above. Global Pharma's Focus on Patient Value and M&A Affecting Rating Profiles As cost pressures on health-care systems rise, payers and regulators have increased their focus on patient value, moving away from the traditional volume-based approach. This shift in policy has acted as a catalyst for recent M&A transactions, as the pharma business models adapt to the shift in incentives. Disparities among EMEA Airlines...
